Sterling Investment Advisors Ltd. lifted its holdings in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS – Free Report) by 3.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 158,695 shares of the company’s stock after buying an additional 5,605 shares during the quarter. Tema Cardiovascular and Metabolics ETF comprises approximately 1.4% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 23rd largest holding. Sterling Investment Advisors Ltd. owned 0.06% of Tema Cardiovascular and Metabolics ETF worth $5,332,000 at the end of the most recent quarter.
Tema Cardiovascular and Metabolics ETF Stock Performance
Shares of NASDAQ:HRTS traded down $0.06 during mid-day trading on Friday, hitting $33.34. 11,352 shares of the company traded hands, compared to its average volume of 24,392. The firm has a market cap of $82.68 million, a P/E ratio of 32.89 and a beta of 0.93. Tema Cardiovascular and Metabolics ETF has a 52-week low of $26.26 and a 52-week high of $36.03. The firm’s 50 day simple moving average is $34.19 and its 200 day simple moving average is $33.34.
About Tema Cardiovascular and Metabolics ETF
Featured Articles
- Five stocks we like better than Tema Cardiovascular and Metabolics ETF
- Why Are These Companies Considered Blue Chips?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- What is a buyback in stocks? A comprehensive guide for investors
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How Investors Can Find the Best Cheap Dividend Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Want to see what other hedge funds are holding HRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS – Free Report).
Receive News & Ratings for Tema Cardiovascular and Metabolics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and related companies with MarketBeat.com's FREE daily email newsletter.